Several new studies have shown as much as a two-fold increase in the risk
of cancers of the colorectum, breast, endometrium, kidney (renal cell
tumors), liver and pancreas among type 2 diabetes patients.  This
seems to be in line with the hypothesis that increased insulin levels
might promote cancer.  This is still a relatively new concept and the
diabetes community is still considering whether type 2 diabetes should
be considered a specific and independent risk factor for these various
forms of cancer.  For the time being, any type 2 diabetic should be
sure to comply with the standard recommendations for cancer screening.

Dr. Mariela Glandt was born in Argentina, received her BA from the University of Pennsylvania, and attended the University of Texas-Houston Medical School. She continued on to a residency in internal medicine at Harvard's Beth Israel Deaconess Hospital in Boston. During residency Dr. Glandt did research on beta cell failure at the Joslin Diabetes Center. She then held an endocrinology fellowship at Columbia Presbyterian Hospital in New York, where her research focused on the reversal of Type I diabetes. Read full bio |